|
Home > Pure
Cardiomyocytes
Cardiomyocyte Products
ReachBio is the Exclusive North American Distributor for
Axiogenesis AG, including the
Cor.At® product line of pure cardiomyocytes and related products.
For a list of products, please
click here.
Cor.At®: Ready-To-Use Pure Cardiomyocytes
Cor.At® atrial cardiomyocytes are produced and genetically selected from mouse embryonic stem (ES) cells using cutting edge technology. They are 99.9% pure, ready to use and functionally normal. They exhibit autonomous contractility and embryonic electrophysiological and gene expression phenotypes. These transgenic cardiomyocytes
express green fluorescent
protein (GFP) reporter gene driven by a cardiac-specific promoter (α-MHC).
The cells generate
cardiac-specific connexin 43 and
show electrical coupling
demonstrated by their
synchronous contractions.
Major applications include:
|
|
 |
Flyer
|
|
|
Technical Bulletin |
|
-
In-vitro model of hypertrophy
- reproduce features of hypertrophic cardiomyocytes
when stimulated with specific agonists
-- increased cell size and sarcomeric organization
-- upregulation of hypertrophy-specific genes
|
|
|
Flyer
|
|
|
Technical Bulletin
|
|
-
Electrophysiology studies
- Represent an authentic cellular environment that
includes all cardiac ion channels (Na+, Ca2+, K+)
- hERG blocker effects
- chronotrophic effects
- arrhythmic effects
- Correct humoral regulation
- Adrenergic and muscarinic effects
|
|
|
Flyer
|
|
|
Technical Bulletin |
|
|
|
|
|
Technical Bulletin |
|
|
|
|
- PatchXpress® 7000A
|
 |
Technical Bulletin
|
|
|
- QPatch |
|
|
|
|
- xCELLigence™ |
|
Application Note |
|
|
- Port-a-Patch®
|
|
Application Note
|
|
|
- Patchliner® |
|
Application Note
|
|
|
|
Flyer
|
|
PatchXpress® is a registered trademark of MDS
Analytical Technologies
xCELLigence™ is a trademark of Roche
Cor.At® is a registered trademark of Axiogenesis
AG
Port-a-Patch® and
Patchliner® are registered
trademarks of Nanion Technologies GmbH
_
Axiogenesis Cor.At® Products
|
Product
|
Description
|
Unit/Format
|
ReachBio Cat. #
|
|
Cor.At® Cells (vials)
|
Cor.At® GFP Cardiomyocytes
•
99.9% pure
•
1 million or 5 million viable cells/vial
•
100 mL Cor.At® Culture Medium for 1 million
cells
•
500 mL Cor.At® Culture Medium for 5 million
cells |
Cryo Vial |
06101
(1 million)
06103
(5 million) |
|
Cor.At® CL
Cells (vials)
|
Cor.At® non-GFP Cardiomyocytes
•
99.9% pure
•
1 million cells/vial
•
100 mL Cor.At® Culture Medium |
Cryo Vial |
06301
|
|
Cor.At® Culture Medium
|
Culture Medium for Cor.At® cardiomyocytes
• Optimized formulation
• Contains pre-qualified supplements
|
100 mL
250 mL
|
06089
(100 mL)
06099
(250 mL) |
|
Cor.At® RNA
(Day 2)
|
Purified RNA from day 2 cultures of Cor.At® cardiomyocytes
|
1 ug
|
06121 |
|
Cor.At® RNA
(Day 14)
|
Purified RNA from day 14 cultures of Cor.At® cardiomyocytes
|
1 ug
|
06122
|
|
Cor.At® RNA
(Day 2 & 14)
|
1 ug of RNA from day 2 plus 1 ug of RNA from day 14 cultures
of Cor.At® cardiomyocytes
|
2 ug
RNA total (1 ug per vial)
|
06133
|
|
Place an order
|
:
|
|
|
Technical questions
|
:
|
|
|
